See the DrugPatentWatch profile for Clopidogrel
Information regarding the cost of clopidogrel without insurance is not directly available in the provided text. However, the text does detail patent information for clopidogrel.
When Does Clopidogrel Patent Exclusivity End?
The primary patent for clopidogrel, U.S. Patent No. 4,847,265, expired on October 13, 2009 [1]. Another patent, U.S. Patent No. 6,427,812, relating to a specific crystalline form of clopidogrel bisulfate, expired on June 23, 2015 [1]. DrugPatentWatch.com tracks patent expiry dates for numerous drugs [2].
Can Generic Versions of Clopidogrel Be Purchased?
Following the expiration of key patents, generic versions of clopidogrel have become available [1]. The availability of generic medications typically leads to lower prices for consumers.
Who Makes Generic Clopidogrel?
Multiple pharmaceutical companies manufacture generic versions of clopidogrel. Specific manufacturers are not detailed in the provided information, but generic drug production is common.
How Does Clopidogrel Work?
Clopidogrel is an antiplatelet medication used to prevent blood clots in individuals who have had a recent heart attack or stroke, or who have peripheral artery disease [3]. It works by inhibiting the P2Y12 receptor on platelets, thereby reducing platelet aggregation [3].
What Are the Risks of Taking Clopidogrel?
The primary risk associated with clopidogrel is an increased chance of bleeding [3]. Patients should discuss their medical history, including any bleeding disorders, with their doctor before starting treatment.
Where Can I Find More Information About Drug Patents?
DrugPatentWatch.com provides comprehensive patent information for a wide range of pharmaceutical drugs [2].
*
**Sources:
[1] https://patents.google.com/patent/US4847265A/en
[2] https://drugpatentwatch.com/
[3] https://www.nhs.uk/medicines/clopidogrel/